Gainers
- NeuroOne Medical Tech NMTC stock moved upwards by 6.47% to $2.63 during Thursday's after-market session. The company's market cap stands at $41.4 million.
- Precision BioSciences DTIL shares increased by 4.6% to $9.55. Today's trading volume for this security ended up closing at 78.5K shares, which is 18.89 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $580.3 million.
- Ocuphire Pharma OCUP stock increased by 4.54% to $3.68. The company's market cap stands at $63.6 million. As per the news, the Q3 earnings report came out 4 days ago.
- Atea Pharmaceuticals AVIR stock increased by 3.59% to $8.93. Trading volume for this security closed at 187.2K, accounting for 4.12% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $742.1 million.
- 180 Life Sciences ATNF stock increased by 3.49% to $4.15. The company's market cap stands at $139.2 million. As per the news, the Q3 earnings report came out 3 days ago.
- TransCode Therapeutics RNAZ shares rose 3.33% to $2.79. The market value of their outstanding shares is at $36.0 million. The company's, Q3 earnings came out 3 days ago.
Losers
- AquaBounty Technologies AQB stock decreased by 15.07% to $2.65 during Thursday's after-market session. This security traded at a volume of 400.1K shares come close, making up 56.26% of its average volume over the last 100 days. The company's market cap stands at $188.2 million.
- Redhill Biopharma RDHL stock fell 11.6% to $3.43. The company's market cap stands at $160.2 million.
- Marker Therapeutics MRKR shares fell 8.74% to $1.15. The company's market cap stands at $95.5 million.
- Cyclacel Pharmaceuticals CYCC stock decreased by 3.04% to $4.15. The company's market cap stands at $41.3 million.
- Biofrontera BFRI stock fell 2.76% to $2.47. The company's market cap stands at $28.6 million.
- Salarius Pharmaceuticals SLRX stock declined by 2.62% to $0.67. The market value of their outstanding shares is at $30.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in